DPP-4 Inhibitors
Sort by:
Cleveland Clinic | 12th Annual Obesity Summit
What To Do After Metformin: GLP-1, SGLT2 or DPP-4?
FEATURING
Kevin Pantalone
- 2,114 views
- December 3, 2017
- 5
UC Davis Health Diabetes and Endocrinology Symposium
Goals of Diabetes Treatment and Considerations in Selecting Diabetes Medications
FEATURING
John Yoon
- 282 views
- November 8, 2018
Cardiology Fiesta 2018
Changing Landscape of CV Treatment in Type 2 Diabetes
- 472 views
- November 28, 2018
- 3
UC Davis Health Diabetes and Endocrinology Symposium
Stepwise Therapy Versus Initial Combination Therapy in Diabetes
FEATURING
John Yoon
- 370 views
- December 6, 2018
- 1
UC Davis Health Diabetes and Endocrinology Symposium
Mixing and Matching Antidiabetic Medications: What's the Best Combination?
FEATURING
John Yoon
- 1,191 views
- December 6, 2018
- 4
3rd National Conference On Prevention Of Diabetes
CV Outcome Trials in Diabetes: The Rest of the Drugs (DPP4-I, Insulin, TZD's, SU's)
FEATURING
Darin Olson
- 548 views
- December 7, 2018
- 2
Inova Heart and Vascular Institute - Advanced Heart Failure Symposium
Diabetocardiology: A New Subspecialty
FEATURING
Eugene Braunwald
- 1,145 views
- January 11, 2019
- 10
Cleveland Clinic Heart, Vascular and Thoracic Institute
ESC 2018 Highlights of Late Breaking Trials
FEATURING
Steven Nissen
- 30 views
- February 5, 2019
23rd Pan Arab Conference On Diabetes
ADA Standards of Care: How the Guidelines can Help us in Patients with Diabetes
FEATURING
Guillermo Umpierrez
- 462 views
- May 13, 2019
23rd Pan Arab Conference On Diabetes
CVD Outcome Trials in T2DM: The Role of Newer Drugs
FEATURING
Peter Gaede
- 473 views
- May 13, 2019
- 2
23rd Pan Arab Conference On Diabetes
Hypoglycemic Risks of New Diabetes Drugs
FEATURING
Darin Olson
- 197 views
- May 14, 2019
- 1
Cardiometabolic Health Congress (CMHC)
Review of Recent CVOTs Results and Clinical Implications
FEATURING
Lawrence Blonde
- 16 views
- October 22, 2019
Diabetes Updates
Best of EASD 2019: CVD Perspective
FEATURING
Peter Gaede
- 167 views
- October 23, 2019
Emory Diabetes Education Training Academy
Antihyperglycemic Medication in Type 2 Diabetes: Overall Approach
FEATURING
Guillermo Umpierrez
- 1,219 views
- May 15, 2020
- 4
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combination Therapy
FEATURING
Guillermo Umpierrez
- 3,780 views
- May 15, 2020
- 22
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Approaches to Treating Diabetes that Reduce CV Events: How Effective Are DPP-4 Inhibitors, GLP1-Receptor Agonists and SGLT-2 Inhibitors in Reducing MACE and Preventing HF Events?
FEATURING
Jia Shen
- 337 views
- February 5, 2021
- 4
Emory Diabetes Education Training Academy
Understanding Oral and Injectable Therapy Options for T2D Care
FEATURING
Sol Jacobs
- 113 views
- April 28, 2021
Scripps Health
Diabetes Treatment 2022 and Cardiovascular Risk
FEATURING
Samantha Harris
- 679 views
- June 1, 2022
- 3
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 3
FEATURING
James Gavin Iii
- 645 views
- November 30, 2023
- 10